BACKGROUND: Adenoviruses (AdVs) can cause serious disease in immunosuppressed patients, particularly those undergoing allogeneic stem cell transplantation. A method for virus quantification in clinical specimens is essential for monitoring patient adenoviral loads and evaluating new therapeutic approaches. METHODS: We developed a PCR-based assay that combines detection and genotyping of human AdVs, targeting a highly conserved region of the adenoviral genome coding for the DNA polymerase (AdV DPol PCR). We tested the diagnostic applicability of this PCR-based assay by analyzing 159 clinical specimens from children with respiratory disease and comparing the results with those obtained by nested PCR analysis. RESULTS: The PCR assay detected all currently known AdV serotypes, with a detection limit of approximately 10 genome equivalents per reaction for 49 of 51 serotypes. No cross-reactivity to human DNA or other DNA viruses was observed. In addition, genotyping of PCR-positive samples was achieved within minutes by fluorescence curve melting analysis in a LightCycler instrument using 6 pairs of hybridization probes, each specific for a single AdV species. Results for clinical specimens were in good concordance with those obtained by nested PCR. CONCLUSION: The presented assay is a suitable tool for the detection and genotyping of human AdVs in clinical samples.
BACKGROUND: Adenoviruses (AdVs) can cause serious disease in immunosuppressed patients, particularly those undergoing allogeneic stem cell transplantation. A method for virus quantification in clinical specimens is essential for monitoring patient adenoviral loads and evaluating new therapeutic approaches. METHODS: We developed a PCR-based assay that combines detection and genotyping of human AdVs, targeting a highly conserved region of the adenoviral genome coding for the DNA polymerase (AdV DPol PCR). We tested the diagnostic applicability of this PCR-based assay by analyzing 159 clinical specimens from children with respiratory disease and comparing the results with those obtained by nested PCR analysis. RESULTS: The PCR assay detected all currently known AdV serotypes, with a detection limit of approximately 10 genome equivalents per reaction for 49 of 51 serotypes. No cross-reactivity to human DNA or other DNA viruses was observed. In addition, genotyping of PCR-positive samples was achieved within minutes by fluorescence curve melting analysis in a LightCycler instrument using 6 pairs of hybridization probes, each specific for a single AdV species. Results for clinical specimens were in good concordance with those obtained by nested PCR. CONCLUSION: The presented assay is a suitable tool for the detection and genotyping of human AdVs in clinical samples.
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Kimberly Starr; Alexander L Greninger; Negar Makhsous; Keith R Jerome; Linda Cook Journal: J Clin Microbiol Date: 2019-10-23 Impact factor: 5.948
Authors: Cicely Washington; David Metzgar; Manzour Hernando Hazbón; Leonard Binn; Arthur Lyons; Carl Coward; Robert Kuschner Journal: J Clin Microbiol Date: 2010-04-21 Impact factor: 5.948
Authors: Meei-Li Huang; Long Nguy; James Ferrenberg; Michael Boeckh; Anne Cent; Lawrence Corey Journal: Diagn Microbiol Infect Dis Date: 2008-08-15 Impact factor: 2.803
Authors: Jan Felix Drexler; Luciano Kleber de Souza Luna; Andreas Stöcker; Patrícia Silva Almeida; Tereza Cristina Medrado Ribeiro; Nadine Petersen; Petra Herzog; Célia Pedroso; Hans Iko Huppertz; Hugo da Costa Ribeiro; Sigrid Baumgarte; Christian Drosten Journal: Emerg Infect Dis Date: 2008-09 Impact factor: 6.883
Authors: Mona S Embarek Mohamed; Janine Reiche; Sonja Jacobsen; Amany G Thabit; Mohamed S Badary; Wolfram Brune; Brunhilde Schweiger; Ahmed H Osmann Journal: Int J Microbiol Date: 2014-01-30